Comments
Loading...
Allogene Therapeutics (ALLO) Forecast
NewsEarningsAllogene Therapeutics (ALLO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAllogene Therapeutics (NASDAQ:ALLO) Stock Quotes, Forecast and News Summary
Allogene Therapeutics Stock (NASDAQ: ALLO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Allogene Therapeutics (ALLO) stock?
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Who are Allogene Therapeutics (ALLO) competitors?
Other companies in Allogene Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN) and Precigen (NASDAQ:PGEN).
What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?
Allogene Therapeutics has a consensus price target of $13.31.
What is the current price for Allogene Therapeutics (ALLO)?
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $2.54 last updated February 20, 2025 at 9:29 AM EST.
Does Allogene Therapeutics (ALLO) pay a dividend?
There are no upcoming dividends for Allogene Therapeutics.
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Allogene Therapeutics (ALLO) going to split?
There is no upcoming split for Allogene Therapeutics.
What sector and industry does Allogene Therapeutics (ALLO) operate in?
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.